Article info
PDFRecent advances in basic science
PPARγ as a new therapeutic target in inflammatory bowel diseases
- Correspondence to:
Dr P Desreumaux
INSERM U795 ex E114, Clinique des Maladies de l’Appareil Digestif et de la Nutrition, Hôpital Swynghedauw, rue A Verhaeghe, F-59037 Lille Cedex, France; pdesreumaux{at}chru-lille.fr
Citation
PPARγ as a new therapeutic target in inflammatory bowel diseases
Publication history
- First published August 11, 2006.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Gut